THE Therapeutic Goods
Administration has approved a new
combined oral contraceptive for
Australian women, Zoely
(nomegestrol acetate/oestradiol).
Zoely is made of a highly-selective
progestogen (nomegestrol acetate -
NOMAC) derived from
progesterone and an oestrogen
(17beta-oestradiol – E2) that is
structurally identical to
endogenous oestrogen produced
naturally in a woman’s body.
The pill delivers 99% contraceptive
efficacy and produces short, light
and less painful withdrawal bleeds
compared to ethinyloestradiol and
drospirenone, with a neutral effect
on acne and weight for most patients.
Zoely is offered in a 24/4
monophasic regimen.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jan 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jan 12
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.